I am incredibly proud to share that Vir Biotechnology, Inc. has received IND clearance and Fast Track designation from the U.S. FDA for our combination therapy, tobevibart and elebsiran, for the treatment of chronic #hepatitis delta infection. This significant milestone, along with the encouraging preliminary data from our Phase 2 SOLSTICE trial, underscores the potential of this treatment to transform the landscape for people living with this severe and life-threatening disease. #PatientsareWaiting
We are thrilled to announce that the U.S. FDA has cleared our IND application and granted Fast Track designation for our investigational combination therapy, tobevibart and elebsiran, for the treatment of chronic #hepatitis delta infection. Learn more here: https://bit.ly/4eFyNx5 #hepatitisdelta #hepatitisD #hepD
#PatientsareWaiting
Congratulations Dr. Marianne an team 💐🌸
That’s incredible news for the hepatitis delta patients !
Congratulations Marianne D. De Backer, MSc, PhD, MBA &team- this is amazing!
Excellent progress - congrats (gefeliciteerd :-) Marianne and team!
Congrats Marianne.
Great progress, Marianne!
CEO at ADIN. Pioneering sustainable solutions within the energy and recycling sectors.
2wThat's a good news